APA aipamena

Shehab, H. M., & Yasmin, H. (2024). A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine. Brac University.

Chicago Style aipamena

Shehab, Habibul Mohsin, and Hasina Yasmin. A Pharmacovigilance Study to Determine Risk of Mortality in Male and Female Patients with Alzheimer's Disease Using Rivastigmine. Brac University, 2024.

MLA aipamena

Shehab, Habibul Mohsin, and Hasina Yasmin. A Pharmacovigilance Study to Determine Risk of Mortality in Male and Female Patients with Alzheimer's Disease Using Rivastigmine. Brac University, 2024.

Kontuz: berrikusi erreferentzia hauek erabili aurretik.